Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
What clinical features define an ideal patient profile for starting lebrikizumab?
1:54
Oct 1, 2025Atopic Dermatitis

What clinical features define an ideal patient profile for starting lebrikizumab?

-

Are most patients beginning lebrikizumab already previously treated with another biologic, or are some biologic-naïve?
0:58
Oct 1, 2025Atopic Dermatitis

Are most patients beginning lebrikizumab already previously treated with another biologic, or are some biologic-naïve?

-

Should dermatologists adjust lebrikizumab dosing in patients who experience flares during maintenance therapy?
2:13
Oct 1, 2025Atopic Dermatitis

Should dermatologists adjust lebrikizumab dosing in patients who experience flares during maintenance therapy?

-

What insights did the ADhere study provide about combining lebrikizumab with topical corticosteroids?
2:10
Oct 1, 2025Atopic Dermatitis

What insights did the ADhere study provide about combining lebrikizumab with topical corticosteroids?

-

What results were seen in the clinical trials for lebrikizumab regarding itch reduction?
1:54
Oct 1, 2025Atopic Dermatitis

What results were seen in the clinical trials for lebrikizumab regarding itch reduction?

-

What laboratory monitoring, if any, is recommended for patients starting and continuing on lebrikizumab?
1:55
Oct 1, 2025Atopic Dermatitis

What laboratory monitoring, if any, is recommended for patients starting and continuing on lebrikizumab?

-

What outcomes have been observed with monthly maintenance dosing of lebrikizumab?
2:58
Oct 1, 2025Atopic Dermatitis

What outcomes have been observed with monthly maintenance dosing of lebrikizumab?

-

How should dermatologists approach patients with AD who appear “mild to moderate” clinically but have significant quality-of-life impairment?
2:02
Oct 1, 2025Atopic Dermatitis

How should dermatologists approach patients with AD who appear “mild to moderate” clinically but have significant quality-of-life impairment?

-

What were the key findings of the ADapt trial, which studied patients switching to lebrikizumab after dupilumab treatment?
3:03
Oct 1, 2025Atopic Dermatitis

What were the key findings of the ADapt trial, which studied patients switching to lebrikizumab after dupilumab treatment?

-

How is chronic hand eczema defined clinically, and how does it differ from atopic dermatitis?
1:19
Aug 8, 2025Eczema

How is chronic hand eczema defined clinically, and how does it differ from atopic dermatitis?

-

What are the major subtypes of CHE, and how can they be differentiated in clinical practice?
1:07
Aug 8, 2025Eczema

What are the major subtypes of CHE, and how can they be differentiated in clinical practice?

-

When should dermatologists consider patch testing in patients with chronic hand eczema?
1:40
Aug 8, 2025Eczema

When should dermatologists consider patch testing in patients with chronic hand eczema?

-

What is the mechanism of action of delgocitinib cream, and how is it relevant to CHE pathophysiology?
1:29
Aug 8, 2025Eczema

What is the mechanism of action of delgocitinib cream, and how is it relevant to CHE pathophysiology?

-

How does delgocitinib differ mechanistically from other topical therapies used for CHE?
2:45
Aug 8, 2025Eczema

How does delgocitinib differ mechanistically from other topical therapies used for CHE?

-

How quickly can patients with CHE expect to see improvement in skin clearance with delgocitinib cream?
2:25
Aug 8, 2025Eczema

How quickly can patients with CHE expect to see improvement in skin clearance with delgocitinib cream?

-

What is known about the durability of response of delgocitinib cream for CHE after treatment discontinuation?
1:55
Aug 8, 2025Eczema

What is known about the durability of response of delgocitinib cream for CHE after treatment discontinuation?

-

Does delgocitinib cream carry a boxed warning, and are there any major safety concerns clinicians should be aware of?
0:50
Aug 8, 2025Eczema

Does delgocitinib cream carry a boxed warning, and are there any major safety concerns clinicians should be aware of?

-

Is routine lab monitoring required for patients on delgocitinib cream?
1:07
Aug 8, 2025Eczema

Is routine lab monitoring required for patients on delgocitinib cream?

-

Can delgocitinib cream for CHE be used on a continuous or as-needed basis depending on flare patterns?
1:42
Aug 8, 2025Eczema

Can delgocitinib cream for CHE be used on a continuous or as-needed basis depending on flare patterns?

-

What is the MyPath Melanoma test, and how does it work?
0:52
Jul 15, 2025Cutaneous Melanoma

What is the MyPath Melanoma test, and how does it work?

-

What types of melanocytic lesions is the MyPath test best suited for?
1:40
Jul 15, 2025Cutaneous Melanoma

What types of melanocytic lesions is the MyPath test best suited for?

-

What is the difference between the MyPath Melanoma test and the DecisionDx-Melanoma test?
2:02
Jul 15, 2025Cutaneous Melanoma

What is the difference between the MyPath Melanoma test and the DecisionDx-Melanoma test?

-

What is the turnaround time for results from the MyPath Melanoma test, and how are results reported?
0:44
Jul 15, 2025Cutaneous Melanoma

What is the turnaround time for results from the MyPath Melanoma test, and how are results reported?

-

Can I order the MyPath Melanoma test on a lesion that has been previously biopsied, or does it need to be planned in advance?
0:33
Jul 15, 2025Cutaneous Melanoma

Can I order the MyPath Melanoma test on a lesion that has been previously biopsied, or does it need to be planned in advance?

-